YB4N.SG : Summary for Mast Therapeutics Inc. Register - Yahoo Finance

U.S. Markets closed

Mast Therapeutics Inc. Register (YB4N.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
0.11-0.00 (-2.68%)
At close: 9:37PM CET
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close0.11
Bid0.00 x 1500000
Ask0.00 x 1500000
Day's Range0.11 - 0.11
52 Week Range0.06 - 0.59
Avg. Volume7,172
Market CapN/A
PE Ratio (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • The Wall Street Journal2 months ago

    [$$] Savara to Merge With Mast Therapeutics

    Specialty pharmaceutical company Savara Inc. said it would secure a New York Stock Exchange listing through a reverse merger with Mast Therapeutics Inc.

  • Investopedia2 months ago

    Mast Therapeutics To Merge With Savara Inc.

    Mast Therapeutics will merge with privately-held Savara Inc, which will be the surviving entity.

  • PR Newswire2 months ago

    Mast Therapeutics And Savara Sign Merger Agreement

    SAN DIEGO and AUSTIN, Texas, Jan. 7, 2017 /PRNewswire/ -- Mast Therapeutics, Inc. (Mast, NYSE MKT: MSTX) and Savara Inc. (Savara), a privately-held emerging specialty pharmaceutical company focused on the treatment of rare respiratory diseases, today announced that the two companies have entered into a definitive merger agreement, under which the stockholders of Savara would become the majority owners of Mast, and the operations of Mast and Savara would be combined.